金十数据5月29日讯，外交部发言人毛宁主持例行记者会，毛宁表示，昨天，王毅外长同基里巴斯总统 兼外长马茂共同主持召开第三次中国-太平洋岛国外长会。王毅外长就构建中国-太平洋岛国命运共同体 提出六点建议，即坚持相互尊重、坚持发展为先、坚持以人民为中心、坚持交流互鉴、坚持公平正义、 坚持同舟共济。会议通过联合声明。中方还发布了落实此次外长会共识的举措清单，包括《中国深化同 太平洋岛国应对气候变化合作倡议》，承诺投入新的资金，扩大同岛国在可持续发展领域合作。 （央 视新闻） 外交部：中国和太平洋岛国为大小国家和平共处树立了标杆 ...

Core Points - The China Securities Regulatory Commission (CSRC) has imposed a fine of 50,000 yuan on Wang Panyi for illegal trading activities involving stocks and convertible bonds [2][8] - Wang Panyi, as a securities practitioner at Pacific Securities Co., Ltd., used a controlled account to buy and sell stocks and convertible bonds from February 2017 to August 2024, resulting in a total purchase of approximately 31.05 million yuan and a sale of about 30.66 million yuan, leading to a loss of around 405,100 yuan [1][6][7] Regulatory Violations - Wang Panyi's actions violated several provisions of the Securities Law, including Article 43, which prohibits certain personnel from trading stocks, and Article 199, which outlines penalties for illegal trading [3][4][7] - The trading of convertible bonds occurred between October 2020 and March 2024, with total purchases of approximately 23,000 yuan and sales of about 27,100 yuan [1][6] Evidence and Proceedings - The investigation was supported by various forms of evidence, including employment certificates, account information, inquiry records, and transaction logs [7] - Wang Panyi did not contest the charges or request a hearing during the investigation process [5][8]

近年来，从业人员违规炒股屡禁不止。证监会此前披露，去年有38名从业人员违规炒股被行政处罚，其 中湘财证券前总裁孙某被罚没金额最大，达到1800万元。今年以来，也有10多名从业人员违规炒股被处 罚或警示。 从业人员炒股罚单频现 炒股7年有余，交易金额达3000多万元，账户亏损逾40万元，还被罚款5万元。券商员工违规炒股不赚反 赔，外加被处罚的案例屡见不鲜。 海南证监局5月28日披露，时任太平洋证券（601099.SH）海口分公司总经理的王某，因违规买卖股票 被处罚。而5个月前，太平洋证券海口分公司还曾因员工违反适当性管理规定被监管出具警示函。 分公司总经理违规炒股被罚 海南证监局披露显示，王攀懿出生于1968年7月，时任太平洋证券海口分公司总经理。此前，海南证监 局已对王攀懿违规买卖股票行为进行了立案调查。 经查明，2017年2月至2024年8月期间，王攀懿作为太平洋证券海口分公司证券从业人员，控制使用"朱 某勇"证券账户买卖股票和可转债，累计买入约3105.29万元，卖出约3065.91万元，账户亏损约40.51万 元（含交易税费等）。其中，可转债的交易时间为2020年10月至2024年3月，累计买入约2.3 ...

王毅会见瓦努阿图外长阿蒂 金十数据5月29日讯，中共中央政治局委员、外交部长王毅在厦门会见来华出席第三次中国—太平洋岛 国外长会的瓦努阿图外长阿蒂。王毅表示，中方欢迎瓦方扩大优质产品对华出口，将继续鼓励中国企业 到瓦投资兴业，期待双方尽早启动双边自贸协定谈判。欢迎瓦方出席建立国际调解院公约的签署仪式。 阿蒂表示，瓦政府愿同中方进一步加强发展战略对接，加快双边自贸协定谈判，推进教育、基建、卫 生、警务等方面合作，将瓦中全面战略伙伴关系提升到新高度 （外交部） 相关链接 ...

西太平洋银行称，美国贸易法院叫停特朗普关税加剧混乱局面，这是"反复无常之处，对美元资产没有 好处"。 ...

【环球时报报道 记者 顾锦东 赵瑜莎】28日，中共中央政治局委员、外交部长王毅同基里巴斯总统兼外 长马茂在厦门共同主持第三次中国—太平洋岛国外长会。这是该会议首次在华线下举办，11个同中国建 交的岛国外长或代表，以及太平洋岛国论坛副秘书长纳亚西应邀参会。与会各方就中国同太平洋岛国关 系及共同关心的议题深入交换意见，达成广泛共识。 第三次中国—太平洋岛国外长会联合声明中说，中方重申习近平主席提出的中国发展同太平洋岛国关系 政策：充分尊重岛国主权和独立，充分尊重岛国意愿，充分尊重岛国民族文化传统，充分尊重岛国联合 自强。强调中国对太平洋岛国的帮助不附加政治条件，不强加于人，不开"空头支票"。 中国国际问题研究院亚太研究所助理研究员林铎接受《环球时报》记者采访时表示，"四个充分尊重"原 则不但精准概括了中国一以贯之的太平洋岛国政策，也是下阶段双方关系全面提质升级的重要航标。 外交部发言人毛宁此前在例行记者会上介绍，中方高度重视同太平洋岛国关系，期待通过此次外长会， 积极落实双方领导人的重要共识，加强团结协作，共谋发展繁荣，携手构建更加紧密的中国—太平洋岛 国命运共同体。 卡塔尔半岛电视台28日援引分析人士的话称，对 ...

Core Viewpoint - The third foreign ministers' meeting between the People's Republic of China and Pacific Island countries took place on May 28-29, 2025, focusing on enhancing cooperation and addressing common concerns [1] Group 1: Cooperation Framework - Participants agreed to promote high-quality integration of the Belt and Road Initiative with the "Blue Pacific 2050 Strategy" to contribute to regional prosperity [1] - A consensus was reached on establishing seven cooperation platforms, including emergency material reserves, climate change response, poverty alleviation, disaster reduction, mycorrhizal grass, agriculture, and police training, with priority areas determined based on national conditions [1] Group 2: Cultural and Economic Exchange - There was a mutual agreement to strengthen exchanges and cooperation in education, culture, tourism, health, and media, as well as to expand local interactions [1] - The parties agreed to explore the economic feasibility of opening more direct flights between China and the Pacific Island countries [1]

Core Viewpoint - Westpac Banking Corporation anticipates that the Reserve Bank of New Zealand will lower the official cash rate to 3% in August instead of July [1] Group 1 - The expected change in the official cash rate reflects a shift in monetary policy timing by the Reserve Bank of New Zealand [1]

Core Insights - Hydrogen transportation is rapidly developing in China, with over ten operational routes exceeding 500 kilometers, notably the 700-kilometer route connecting Luliang Xiaoyi and Tianjin Port [1][2] - The Luliang Xiaoyi to Tianjin Port route is the first long-distance commercial zero-carbon logistics corridor in China, utilizing hydrogen-powered heavy trucks that emit only water during operation [1][2] - The transition from coal-based economy to hydrogen energy in Luliang is crucial for achieving a green transformation, as the region has significant coal resources [1][2] Industry Developments - The performance of hydrogen heavy trucks has significantly improved, with the range increasing from 350 kilometers to 650 kilometers, while purchase costs have decreased, facilitating large-scale adoption [2] - The establishment of a hydrogen refueling station network is essential for operational efficiency, exemplified by the North Yao Hydrogen Comprehensive Energy Island, which can supply 8,000 kilograms of hydrogen daily [2] - The current logistics primarily transport coal, replacing high-pollution fuel trucks, and future operations will incorporate advanced monitoring technologies to enhance efficiency and reduce costs [2] Competitive Landscape - China has surpassed Germany in the hydrogen transportation sector due to its large market, industrial integration capabilities, and favorable policies, despite Germany's technological advantages [2] - The competition between China and Germany in the hydrogen sector is expected to accelerate the global energy transition process [2]

报告摘要 市场表现： 2025 年5 月23 日，医药板块涨跌幅+0.42%，跑赢沪深300 指数1.23pct，涨跌幅居申万31 个子行业第2 名。各医药子行业中，医疗设备(+1.43%)、医疗研发外包(+0.98%)、线下药店（+0.74%）表现居前，疫 苗（-0.68%)、血液制品(-0.43%)、医院（-0.27%)表现居后。个股方面，日涨幅榜前3 位分别为新天地 (+20.02%)、海辰药业(+20.00%)、多瑞医药(+20.00%)；跌幅榜前3 位为亚虹医药（-5.86%）、百济神州 (-4.15%)、润都股份（-3.94%)。 行业要闻： 近日，GSK 宣布，美国FDA 批准其"first-in-class"抗体疗法Nucala（Mepolizumab）作为辅助维持治疗， 用于伴有嗜酸性粒细胞表型、病情控制不佳的成人慢性阻塞性肺病（COPD）患者。Nucala 是一种靶向 IL-5的单克隆抗体，已开发用于治疗一系列与2 型炎症相关的IL-5 介导疾病。 该药是首个在临床表现多样COPD 人群中开展研究并获批用于嗜酸性粒细胞表型患者的生物制品，该疾 病表型以血液嗜酸性粒细胞计数（BEC）≥150 ...